Neulasta, Injektionslösung in einer Fertigspritze

7680563260047 CH-56326 Injektionslösung

Associated product:

NEULASTA 6 mg/0.6ml sécurisée ser pré
Neulasta, Injektionslösung in einer Fertigspritze
Neulasta, Injektionslösung in einer Fertigspritze
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Spritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/07/2021
Patient information leaflet
Français
23/07/2021
Patient information leaflet
Italien
23/07/2021
Summary of Product Characteristics
Allemand
23/07/2021
Summary of Product Characteristics
Français
23/07/2021
Summary of Product Characteristics
Italien
23/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
6.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
20.4 UG Substance HBESI
(N/A)
30.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 1287.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2003

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
56326
Drug name
Neulasta, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L03AA13
Authorization status
Z
Dispensing category
A
First authorization
01/09/2003
Authorization expiration date
31/12/9999
IT Number
06.07.3.
Domain
Human medicine
Field of application
Neutropenie

Package details

Description (FR)
NEULASTA 6 mg/0.6ml sécurisée ser pré
Description (DE)
NEULASTA 6 mg/0.6ml m Nadelschutz Fertspr
Market launch
01/09/2003
Narcotic (BTM)
No

Other package sizes (4)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
NEULASTA 6 mg/0.6ml sécurisée ser pré 24 pce
None None
GTIN: 7680563260061
Not in V1